These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 9221943)
1. Antinociceptive involvement of substance P in the spinal cord of mice: dose effects of substance P on the behavior elicited by intrathecally administered NMDA. Masuyama T; Shimizu T Brain Res; 1997 Jun; 759(2):241-6. PubMed ID: 9221943 [TBL] [Abstract][Full Text] [Related]
2. Spinal antinociceptive effect of substance P on the responses induced by intrathecally injected NMDA in mice. Masuyama T; Shimizu T; Iwashita T; Yoshimura N; Fukuda T Brain Res; 1996 May; 722(1-2):200-2. PubMed ID: 8813368 [TBL] [Abstract][Full Text] [Related]
3. CP-96,345, which inhibits [3H] substance P binding, selectively inhibits the behavioral response to intrathecally administered N-methyl-D-aspartate, but not substance P, in the mouse. Velázquez RA; Kitto KF; Larson AA J Pharmacol Exp Ther; 1997 Jun; 281(3):1231-7. PubMed ID: 9190858 [TBL] [Abstract][Full Text] [Related]
4. Regulation of sigma activity by the amino-terminus of substance P in the mouse spinal cord: involvement of phencyclidine (PCP) sites not linked to N-methyl-D-aspartate (NMDA) activity. Larson AA; Sun X Neuropharmacology; 1993 Sep; 32(9):909-17. PubMed ID: 7694172 [TBL] [Abstract][Full Text] [Related]
5. The effects of substance P analogues on the scratching, biting and licking response induced by intrathecal injection of N-methyl-D-aspartate in mice. Sakurada T; Manome Y; Tan-No K; Sakurada S; Kisara K Br J Pharmacol; 1990 Oct; 101(2):307-10. PubMed ID: 1701675 [TBL] [Abstract][Full Text] [Related]
6. The NH2-terminus of substance P modulates NMDA-induced activity in the mouse spinal cord. Hornfeldt CS; Sun X; Larson AA J Neurosci; 1994 May; 14(5 Pt 2):3364-9. PubMed ID: 7514216 [TBL] [Abstract][Full Text] [Related]
7. Behavioral sensitization to kainic acid and quisqualic acid in mice: comparison to NMDA and substance P responses. Sun XF; Larson AA J Neurosci; 1991 Oct; 11(10):3111-23. PubMed ID: 1719157 [TBL] [Abstract][Full Text] [Related]
8. Intrathecally administered big dynorphin, a prodynorphin-derived peptide, produces nociceptive behavior through an N-methyl-D-aspartate receptor mechanism. Tan-No K; Esashi A; Nakagawasai O; Niijima F; Tadano T; Sakurada C; Sakurada T; Bakalkin G; Terenius L; Kisara K Brain Res; 2002 Oct; 952(1):7-14. PubMed ID: 12363399 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin (1-7) Attenuates the Nociceptive Behavior Induced by Substance P and NMDA via Spinal MAS1. Yamagata R; Nemoto W; Fujita M; Nakagawasai O; Tan-No K Biol Pharm Bull; 2021; 44(5):742-746. PubMed ID: 33952831 [TBL] [Abstract][Full Text] [Related]
11. Dose-related opposite modulation by nociceptin/orphanin FQ of substance P nociception in the nociceptors and spinal cord. Inoue M; Shimohira I; Yoshida A; Zimmer A; Takeshima H; Sakurada T; Ueda H J Pharmacol Exp Ther; 1999 Oct; 291(1):308-13. PubMed ID: 10490918 [TBL] [Abstract][Full Text] [Related]
12. Spinal nociceptin inhibits septide but not N-methyl-D-aspartate-induced nociceptive behavior in rats. Villanueva N; Lastra A; Hidalgo A; Baamonde A; Menéndez L Eur J Pharmacol; 2002 Jun; 445(1-2):83-6. PubMed ID: 12065197 [TBL] [Abstract][Full Text] [Related]
13. Involvement of multiple µ-opioid receptor subtypes on the presynaptic or postsynaptic inhibition of spinal pain transmission. Mizoguchi H; Takagi H; Watanabe C; Yonezawa A; Sato T; Sakurada T; Sakurada S Peptides; 2014 Jan; 51():15-25. PubMed ID: 24512946 [TBL] [Abstract][Full Text] [Related]
14. Release of substance P by intrathecal KK-3, a newly synthesized Leu-enkephalin derivative. Takahashi M; Tokuyama S; Kaneto H Pharmacol Biochem Behav; 1989 Aug; 33(4):843-6. PubMed ID: 2482510 [TBL] [Abstract][Full Text] [Related]
15. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Sakurada T; Katsumata K; Tan-No K; Sakurada S; Kisara K Neuropharmacology; 1992 Dec; 31(12):1279-85. PubMed ID: 1281912 [TBL] [Abstract][Full Text] [Related]
17. Intrathecal substance P augments morphine-induced antinociception: possible relevance in the production of substance P N-terminal fragments. Komatsu T; Sasaki M; Sanai K; Kuwahata H; Sakurada C; Tsuzuki M; Iwata Y; Sakurada S; Sakurada T Peptides; 2009 Sep; 30(9):1689-96. PubMed ID: 19520130 [TBL] [Abstract][Full Text] [Related]
18. Differential inhibitory effects of mu-opioids on substance P- and capsaicin-induced nociceptive behavior in mice. Watanabe H; Nakayama D; Yuhki M; Sawai T; Sakurada W; Katsuyama S; Hayashi T; Watanabe C; Mizoguchi H; Fujimura T; Sakurada T; Sakurada S Peptides; 2006 Apr; 27(4):760-8. PubMed ID: 16226344 [TBL] [Abstract][Full Text] [Related]
19. Antinociceptive effects of intrathecal taurine and calcium in the mouse. Hornfeldt CS; Smullin DH; Schamber CD; Sun X; Larson AA Life Sci; 1992; 50(24):1925-34. PubMed ID: 1375974 [TBL] [Abstract][Full Text] [Related]
20. An antagonist of substance P N-terminal fragments, D-substance P(1-7), reveals that both nociceptive and antinociceptive effects are induced by substance P N-terminal activity during noxious chemical stimulation. Goettl VM; Larson AA Brain Res; 1998 Jan; 780(1):80-5. PubMed ID: 9473599 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]